Caraway Therapeutics
Industry
- Pharmaceuticals
- Biotechnology
Other Names/Subsidiaries
- Rheostat Therapeutics
See more in Biomedtracker
Latest on Caraway Therapeutics
In Vivo
• By David Wild
It has been a challenging month for Bethesda, Maryland-based Gain Therapeutics, Inc. Shares of the company have fallen dramatically since 14 June, when it priced a public offering to raise $11m. The
Scrip
• By Alaric DeArment
Merck & Co., Inc. is making its latest foray into drugs targeting a lysosomal ion channel that plays a role in neurodegenerative diseases with its acquisition of Caraway Therapeutics , a venture cap
Scrip
• By Joseph Haas
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie, Caraway Research Targets TMEM17